Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on October 1, 2026

Oct. 1, 2026

What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?

Indeterminate GlobeNewswire

Oct. 1, 2026

One of the most remote infrastructure projects in the US takes shape in Alaska

Indeterminate GlobeNewswire

Oct. 1, 2026

Yukon Metals Intersects 23.5 Metres of 0.48 G/T Gold and 0.11% Copper Near Surface, Extending Birch Skarn System to Approximately 1 Kilometre of Drilled Strike

Indeterminate GlobeNewswire

Oct. 1, 2026

PyroGenesis Confirms Completion of Installation of 4.5 MW Plasma Torch System at U.S. Defense and Aeronautics Research Facility

Indeterminate GlobeNewswire

Oct. 1, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

Indeterminate GlobeNewswire

Oct. 1, 2026

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Indeterminate GlobeNewswire

Oct. 1, 2026

Fairtrade Month Launches on a Historic High: Canadian Sales Generate $10 Million for Farmers Worldwide

Indeterminate GlobeNewswire

Oct. 1, 2026

Le Mois du commerce équitable démarre en force : les ventes canadiennes génèrent 10 millions de dollars pour les producteurs du monde entier

Indeterminate GlobeNewswire

Oct. 1, 2026

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Amplify ETFs Highlights HACK and HAKY During Cybersecurity Awareness Month

Indeterminate GlobeNewswire

Oct. 1, 2026

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

Fervo Energy Declares Commercial Operation at Cape Station Ahead of Schedule, Leading the Race for Next-Generation Geothermal Energy

Indeterminate GlobeNewswire

Oct. 1, 2026

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Indeterminate GlobeNewswire

Oct. 1, 2026

USA Rare Earth Completes CEO Transition

Indeterminate GlobeNewswire

Oct. 1, 2026

Origin Agritech Strengthens Liquidity by Selling Its Xinjiang Seed Subsidiary and Leasing Back the Production Base

Indeterminate GlobeNewswire

Oct. 1, 2026

BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio

Indeterminate GlobeNewswire

Oct. 1, 2026

Controlled Thermal Resources and Plum Acquisition Corp. IV Announce Strengthened Capital Structure to Advance Hell’s Kitchen Geothermal Power and Critical Minerals Project

Indeterminate GlobeNewswire